Infinity Pharmaceuticals Profile

2.28
USD 0.12  5%
1.14Last Month High 3.73 
2.26Trading Day  High 2.45 

Purchase by Bvf Partners L P of 63042 shares of Infinity Pharmaceuticals

Infinity Pharmaceuticals Inc insider trading alert for perchase of common stock $0.001 par value by Bvf Partners L P, the corporate stakeholder, on October 5, 2017. This event was filed by Infinity Pharmaceuticals with SEC on 2017-10-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Infinity Pharmaceuticals Summary

Infinity Pharmaceuticals Inc (INFI) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 48 people. Infinity Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 149.53 M. Infinity Pharmaceuticals Inc has 50.69 M outstanding shares of which 1.39 M shares are currently shorted by private and institutional investors with about 4.0 trading days to cover. INFINITY PHARMACE currently holds about 66.2 M in cash with (82.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Check Infinity Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Acadian Asset Management LlcCommon Shares37 K49 K
American Financial Network Advisory Services LlcCommon Shares1280.0
View Infinity Pharmaceuticals Diagnostics

Selected Infinity Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Infinity Pharmaceuticals Against Markets

Current Ratings  

Infinity Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
13 
Chance of
< 63% 
Infinity Pharmaceuticals, Inc., a drug discovery and development company, discovers, develops, and delivers medicines to patients with difficulttotreat diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameInfinity Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business Address784 Memorial Drive, Cambridge, MA 02139, United States
ExchangeNASDAQ
CIK Number01113148.0
CUSIP45665G303
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.infi.com
Contact Number617 453 1000
CurrencyUSD - US Dollar

Recommendations

Infinity Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
2.0Hold3Odds
Infinity Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Infinity Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Infinity Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.56February 28, 2017
Infinity Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate